Why can't I see Empower Pharmacy pricing before I commit?

The pricing transparency problem shows up at the worst moment: a patient is in front of you, ready to start semaglutide or tirzepatide, and you cannot give them a number. You either guess, quote a padded figure to be safe, or tell the patient you will follow up — and follow-ups are where conversions go to die. On Empower Pharmacy, per-vial cost is not visible in the product catalog; it requires a clinic liaison conversation that itself requires the setup call your team completed during onboarding.

For owners, the same opacity makes margin planning a moving target. If pricing is known only through a liaison negotiation and can shift with volume tiers or formulary updates, modeling a cash-pay GLP-1 program means estimating rather than knowing. The delay is not just minutes in a consult; it is the inability to run a confident, numbers-driven practice.

Empower Pharmacy's pricing is accessed through its clinic liaison process — a deliberate model that allows for organization-specific pricing agreements rather than a public price sheet. This is common among 503A compounders and can yield favorable rates at volume. The trade-off is structural: you cannot browse pricing before the liaison conversation, you cannot verify current rates are on screen before placing an order, and any tier or formulary change typically surfaces through the liaison rather than in the portal.

Empower Pharmacy's FAQ is explicit on this: 'This is required in order to access a pricing catalog.' The 'required' language is not a soft suggestion — it is the documented entry point. For a clinic evaluating whether Empower Pharmacy's economics work before committing to a full account setup, there is no guest pricing view, no public catalog price, and no shortcut around the liaison step.

The delay disappears when pricing is visible at the point of decision. Fizy Health shows resolved per-vial 503A cost on each catalog and cart line before checkout, with the facilitation fee disclosed at payment. A clinician can quote a patient in the room, an owner can model margin from real numbers, and neither has to wait for a liaison call or a catalog that requires account access to view. There is no gate between you and the cost of the medication you are about to order.

Pass-through pricing is the structural difference: instead of a negotiated rate that arrives through a liaison and lives in a sales conversation, you see the 503A pharmacy cost and the disclosed facilitation fee on each line. The evaluation test is whether you can answer 'what does this vial cost?' without making a call. When the catalog answers that question, the consult keeps moving and pricing stops being a bottleneck.